Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001576280-25-000277
Filing Date
2025-10-29
Accepted
2025-10-29 17:13:13
Documents
84
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gh-20250930.htm   iXBRL 10-Q 1587538
2 EX-31.1 gh-9302025x10qxex311.htm EX-31.1 10195
3 EX-31.2 gh-9302025x10qxex312.htm EX-31.2 10187
4 EX-31.3 gh-9302025x10qxex313.htm EX-31.3 10291
5 EX-32.1 gh-9302025x10qxex321.htm EX-32.1 5854
6 EX-32.2 gh-9302025x10qxex322.htm EX-32.2 5856
7 EX-32.3 gh-9302025x10qxex323.htm EX-32.3 5897
  Complete submission text file 0001576280-25-000277.txt   9184076

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gh-20250930.xsd EX-101.SCH 53385
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gh-20250930_cal.xml EX-101.CAL 89572
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gh-20250930_def.xml EX-101.DEF 319925
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gh-20250930_lab.xml EX-101.LAB 744392
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gh-20250930_pre.xml EX-101.PRE 532220
87 EXTRACTED XBRL INSTANCE DOCUMENT gh-20250930_htm.xml XML 1526046
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

EIN.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38683 | Film No.: 251430955
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)